{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:47:29Z","timestamp":1793850449922,"version":"4.6.1"},"reference-count":21,"publisher":"American Society of Hematology","issue":"20","license":[{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Cellular ontogeny and MLL breakpoint site influence the capacity of MLL-edited CD34+ hematopoietic cells to initiate and recapitulate infant patients' features in pro\u2013B-cell acute lymphoblastic leukemia (B-ALL). We provide key insights into the leukemogenic determinants of MLL-AF4+ infant B-ALL.<\/jats:p>","DOI":"10.1182\/blood.2023020858","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T19:11:00Z","timestamp":1695841860000},"page":"1752-1756","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":11,"title":["A human genome editing\u2013based <i>MLL<\/i>::<i>AF4<\/i> ALL model recapitulates key cellular and molecular leukemogenic features"],"prefix":"10.1182","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1442-6216","authenticated-orcid":false,"given":"Clara","family":"Bueno","sequence":"first","affiliation":[{"name":"1Stem Cell Biology, Immunotherapy and Developmental Leukemia Laboratory. Josep Carreras Leukemia Research Institute, Barcelona, Spain"},{"name":"2Spanish Network for Advanced Therapies, Carlos III Health Institute, Barcelona, Spain"},{"name":"3Spanish Collaborative Cancer Network, Carlos III Health Institute, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9606-0398","authenticated-orcid":false,"given":"Raul","family":"Torres-Ruiz","sequence":"additional","affiliation":[{"name":"1Stem Cell Biology, Immunotherapy and Developmental Leukemia Laboratory. Josep Carreras Leukemia Research Institute, Barcelona, Spain"},{"name":"4Division of Hematopoietic Innovative Therapies, Biomedical Innovation Unit, Centro de Investigaciones Energ\u00e9ticas, Medioambientales y Tecnol\u00f3gicas, Madrid, Spain"},{"name":"5Advanced Therapies Unit, Instituto de Investigaci\u00f3n Sanitaria Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain"},{"name":"6Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras, Madrid, Spain"},{"name":"7Molecular Cytogenetics and Genome Editing Unit, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2183-7443","authenticated-orcid":false,"given":"Talia","family":"Velasco-Hernandez","sequence":"additional","affiliation":[{"name":"1Stem Cell Biology, Immunotherapy and Developmental Leukemia Laboratory. Josep Carreras Leukemia Research Institute, Barcelona, Spain"},{"name":"2Spanish Network for Advanced Therapies, Carlos III Health Institute, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7585-4519","authenticated-orcid":false,"given":"Oscar","family":"Molina","sequence":"additional","affiliation":[{"name":"1Stem Cell Biology, Immunotherapy and Developmental Leukemia Laboratory. Josep Carreras Leukemia Research Institute, Barcelona, Spain"},{"name":"2Spanish Network for Advanced Therapies, Carlos III Health Institute, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Petazzi","sequence":"additional","affiliation":[{"name":"1Stem Cell Biology, Immunotherapy and Developmental Leukemia Laboratory. Josep Carreras Leukemia Research Institute, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Martinez","sequence":"additional","affiliation":[{"name":"1Stem Cell Biology, Immunotherapy and Developmental Leukemia Laboratory. Josep Carreras Leukemia Research Institute, Barcelona, Spain"},{"name":"2Spanish Network for Advanced Therapies, Carlos III Health Institute, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"1Stem Cell Biology, Immunotherapy and Developmental Leukemia Laboratory. Josep Carreras Leukemia Research Institute, Barcelona, Spain"},{"name":"2Spanish Network for Advanced Therapies, Carlos III Health Institute, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1906-4701","authenticated-orcid":false,"given":"Meritxell","family":"Vinyoles","sequence":"additional","affiliation":[{"name":"1Stem Cell Biology, Immunotherapy and Developmental Leukemia Laboratory. Josep Carreras Leukemia Research Institute, Barcelona, Spain"},{"name":"2Spanish Network for Advanced Therapies, Carlos III Health Institute, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1986-7873","authenticated-orcid":false,"given":"Sandra","family":"Cantilena","sequence":"additional","affiliation":[{"name":"8Development Biology Cancer Program, Cancer Section, UCLGOS Institute of Child Health, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"Williams","sequence":"additional","affiliation":[{"name":"8Development Biology Cancer Program, Cancer Section, UCLGOS Institute of Child Health, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3190-063X","authenticated-orcid":false,"given":"Nerea","family":"Vega-Garcia","sequence":"additional","affiliation":[{"name":"9Hematology Laboratory, Hospital Sant Joan de D\u00e9u Barcelona, Barcelona, Spain"},{"name":"10Developmental Tumors Biology Group, Leukemia, and other Pediatric Hemopathies, Pediatric Cancer Center Barcelona, Institut de Recerca, Hospital Sant Joan de D\u00e9u, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7221-3636","authenticated-orcid":false,"given":"Sandra","family":"Rodriguez-Perales","sequence":"additional","affiliation":[{"name":"7Molecular Cytogenetics and Genome Editing Unit, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4101-6124","authenticated-orcid":false,"given":"Jose C.","family":"Segovia","sequence":"additional","affiliation":[{"name":"4Division of Hematopoietic Innovative Therapies, Biomedical Innovation Unit, Centro de Investigaciones Energ\u00e9ticas, Medioambientales y Tecnol\u00f3gicas, Madrid, Spain"},{"name":"5Advanced Therapies Unit, Instituto de Investigaci\u00f3n Sanitaria Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain"},{"name":"6Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6869-7006","authenticated-orcid":false,"given":"Oscar","family":"Quintana-Bustamante","sequence":"additional","affiliation":[{"name":"4Division of Hematopoietic Innovative Therapies, Biomedical Innovation Unit, Centro de Investigaciones Energ\u00e9ticas, Medioambientales y Tecnol\u00f3gicas, Madrid, Spain"},{"name":"5Advanced Therapies Unit, Instituto de Investigaci\u00f3n Sanitaria Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain"},{"name":"6Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anindita","family":"Roy","sequence":"additional","affiliation":[{"name":"11MRC Molecular Hematology Unit, MRC Weatherall Institute of Molecular Medicine, Oxford Biomedical Research Center Hematology Theme, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom"},{"name":"12Department of Pediatrics and National Institute for Health and Care Research Oxford Biomedical Research Centre Hematology Theme, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Meyer","sequence":"additional","affiliation":[{"name":"13Diagnostic Center of Acute Leukemia\u2013Institute of Pharmaceutical Biology, Goethe-University, Frankfurt\/Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4870-3445","authenticated-orcid":false,"given":"Rolf","family":"Marschalek","sequence":"additional","affiliation":[{"name":"13Diagnostic Center of Acute Leukemia\u2013Institute of Pharmaceutical Biology, Goethe-University, Frankfurt\/Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6330-1407","authenticated-orcid":false,"given":"Alastair L.","family":"Smith","sequence":"additional","affiliation":[{"name":"11MRC Molecular Hematology Unit, MRC Weatherall Institute of Molecular Medicine, Oxford Biomedical Research Center Hematology Theme, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0413-4271","authenticated-orcid":false,"given":"Thomas A.","family":"Milne","sequence":"additional","affiliation":[{"name":"11MRC Molecular Hematology Unit, MRC Weatherall Institute of Molecular Medicine, Oxford Biomedical Research Center Hematology Theme, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8450-2603","authenticated-orcid":false,"given":"Mario F.","family":"Fraga","sequence":"additional","affiliation":[{"name":"6Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras, Madrid, Spain"},{"name":"14Cancer Epigenetics and Nanomedicine Laboratory, Nanomaterials and Nanotechnology Research Center, El Entrego, Spain"},{"name":"15Health Research Institute of Asturias, Institute of Oncology of Asturias and Department of Organisms and Systems Biology, University of Oviedo, Oviedo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4061-9698","authenticated-orcid":false,"given":"Juan Ram\u00f3n","family":"Tejedor","sequence":"additional","affiliation":[{"name":"6Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras, Madrid, Spain"},{"name":"14Cancer Epigenetics and Nanomedicine Laboratory, Nanomaterials and Nanotechnology Research Center, El Entrego, Spain"},{"name":"15Health Research Institute of Asturias, Institute of Oncology of Asturias and Department of Organisms and Systems Biology, University of Oviedo, Oviedo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9372-1007","authenticated-orcid":false,"given":"Pablo","family":"Men\u00e9ndez","sequence":"additional","affiliation":[{"name":"1Stem Cell Biology, Immunotherapy and Developmental Leukemia Laboratory. Josep Carreras Leukemia Research Institute, Barcelona, Spain"},{"name":"2Spanish Network for Advanced Therapies, Carlos III Health Institute, Barcelona, Spain"},{"name":"3Spanish Collaborative Cancer Network, Carlos III Health Institute, Barcelona, Spain"},{"name":"16Department of Biomedicine, University of Barcelona, Barcelona, Spain"},{"name":"17Instituci\u00f3 Catalana de Recerca i Estudis Avan\u00e7ats, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"25","key":"2023111616203796200_bib1","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1182\/blood-2015-09-667378","article-title":"Revisiting the biology of infant t(4;11)\/MLL-AF4+ B-cell acute lymphoblastic leukemia","volume":"126","author":"Sanjuan-Pla","year":"2015","journal-title":"Blood"},{"issue":"2","key":"2023111616203796200_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/leu.2017.213","article-title":"The MLL recombinome of acute leukemias in 2017","volume":"32","author":"Meyer","year":"2018","journal-title":"Leukemia"},{"issue":"6","key":"2023111616203796200_bib3","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.3324\/haematol.2018.206375","article-title":"Unraveling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis","volume":"104","author":"Agraz-Doblas","year":"2019","journal-title":"Haematologica"},{"issue":"4","key":"2023111616203796200_bib4","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ng.3230","article-title":"The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias","volume":"47","author":"Andersson","year":"2015","journal-title":"Nat Genet"},{"issue":"4","key":"2023111616203796200_bib5","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/sj.leu.2404598","article-title":"Age-related differences in leukemia biology and prognosis: the paradigm of MLL-AF4-positive acute lymphoblastic leukemia","volume":"21","author":"Pui","year":"2007","journal-title":"Leukemia"},{"issue":"4","key":"2023111616203796200_bib6","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/leu.2010.14","article-title":"Bimodal distribution of genomic MLL breakpoints in infant acute lymphoblastic leukemia treatment","volume":"24","author":"Jung","year":"2010","journal-title":"Leukemia"},{"issue":"23","key":"2023111616203796200_bib7","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1038\/sj.onc.1204401","article-title":"Biased distribution of chromosomal breakpoints involving the MLL gene in infants versus children and adults with t(4;11) ALL","volume":"20","author":"Reichel","year":"2001","journal-title":"Oncogene"},{"key":"2023111616203796200_bib8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.exphem.2020.10.002","article-title":"HOXA9\/IRX1 expression pattern defines two subgroups of infant MLL-AF4-driven acute lymphoblastic leukemia","volume":"93","author":"Symeonidou","year":"2021","journal-title":"Exp Hematol"},{"issue":"8","key":"2023111616203796200_bib9","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1158\/0008-5472.CAN-15-2769","article-title":"Activated KRAS cooperates with MLL-AF4 to promote extramedullary engraftment and migration of cord blood CD34+ HSPC but is insufficient to initiate leukemia","volume":"76","author":"Prieto","year":"2016","journal-title":"Cancer Res"},{"issue":"5","key":"2023111616203796200_bib10","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ccell.2016.10.008","article-title":"Instructive role of MLL-fusion proteins revealed by a model of t(4;11) pro-B acute lymphoblastic leukemia","volume":"30","author":"Lin","year":"2016","journal-title":"Cancer Cell"},{"issue":"11","key":"2023111616203796200_bib11","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1182\/blood.2019000893","article-title":"Natural history and cell of origin of TC F3-ZN F384 and PTPN11 mutations in monozygotic twins with concordant BCP-ALL","volume":"134","author":"Bueno","year":"2019","journal-title":"Blood"},{"issue":"3","key":"2023111616203796200_bib12","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/leu.2013.346","article-title":"Ligand-independent FLT3 activation does not cooperate with MLL-AF4 to immortalize\/transform cord blood CD34+ cells","volume":"28","author":"Montes","year":"2014","journal-title":"Leukemia"},{"issue":"1","key":"2023111616203796200_bib13","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.1038\/s41467-021-27270-z","article-title":"A\u00a0human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program","volume":"12","author":"Rice","year":"2021","journal-title":"Nat Commun"},{"issue":"6","key":"2023111616203796200_bib14","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.3390\/cancers12061487","article-title":"Only hematopoietic stem and progenitor cells from cord blood are susceptible to malignant transformation by MLL-AF4 translocations","volume":"12","author":"Secker","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"23","key":"2023111616203796200_bib15","doi-asserted-by":"crossref","first-page":"35341","DOI":"10.18632\/oncotarget.9241","article-title":"The IRX1\/HOXA connection: insights into a novel t(4;11)- specific cancer mechanism","volume":"7","author":"Kuhn","year":"2016","journal-title":"Oncotarget"},{"issue":"14","key":"2023111616203796200_bib16","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1182\/blood-2009-07-233049","article-title":"Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants","volume":"115","author":"Stam","year":"2010","journal-title":"Blood"},{"issue":"5","key":"2023111616203796200_bib17","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1600-0609.2009.01305.x","article-title":"Two independent gene signatures in pediatric t(4;11) acute lymphoblastic leukemia patients","volume":"83","author":"Trentin","year":"2009","journal-title":"Eur J Haematol"},{"issue":"5","key":"2023111616203796200_bib18","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/s41375-023-01877-1","article-title":"The KMT2A recombinome of acute leukemias in 2023","volume":"37","author":"Meyer","year":"2023","journal-title":"Leukemia"},{"issue":"7","key":"2023111616203796200_bib19","doi-asserted-by":"crossref","first-page":"104613","DOI":"10.1016\/j.isci.2022.104613","article-title":"The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemia","volume":"25","author":"Kulp","year":"2022","journal-title":"iScience"},{"issue":"2","key":"2023111616203796200_bib20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1128\/MCB.24.2.617-628.2004","article-title":"Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization","volume":"24","author":"Zeisig","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"17","key":"2023111616203796200_bib21","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1182\/blood.2021015036","article-title":"Epigenetic regulator genes direct lineage switching in MLL\/AF4 leukemia","volume":"140","author":"Tirtakusuma","year":"2022","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/142\/20\/1752\/2088911\/blood_bld-2023-020858-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/142\/20\/1752\/2088911\/blood_bld-2023-020858-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T16:21:45Z","timestamp":1700151705000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/142\/20\/1752\/498120\/A-human-genome-editing-based-MLL-AF4-ALL-model"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,16]]},"references-count":21,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2023,11,16]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2023020858","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,16]]}}}